BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17038001)

  • 41. [Treatment of severe acquired aplastic anemia].
    Jacobsen N
    Nord Med; 1995; 110(12):314-5. PubMed ID: 8524632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone marrow graft versus ALG in patients with aplastic anaemia.
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
    Biomed Pharmacother; 1983; 37(3):139-43. PubMed ID: 6357304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy of immunosuppressive therapy for children with aplastic anemia].
    Wang YC; Yin CY; Feng L; Wang CM; Ma LN; Wei YW; Sheng GY
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan; 14(1):33-7. PubMed ID: 22289749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection.
    Storb R; Prentice RL; Thomas ED
    N Engl J Med; 1977 Jan; 296(2):61-6. PubMed ID: 136605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Second bone marrow transplantation for severe aplastic anemia: analysis of 34 cases.
    de Medeiros CR; Bitencourt MA; Medeiros BC; Ioshizumi L; Pasquini R
    Bone Marrow Transplant; 2001 Nov; 28(10):941-4. PubMed ID: 11753548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experience in the use of allogeneic bone marrow transplantation in severe forms of aplastic anemia at the Byelorussian hematological center].
    Uss AL; Zmachinskiĭ VA; Milanovich NF; Skriagin AE; Batan ZE; Dziuba EV; Mitskevich PB; Smirnova LA
    Ter Arkh; 1999; 71(7):69-72. PubMed ID: 10481871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.
    Kojima S; Horibe K; Inaba J; Yoshimi A; Takahashi Y; Kudo K; Kato K; Matsuyama T
    Br J Haematol; 2000 Oct; 111(1):321-8. PubMed ID: 11091219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children.
    Hale GA; Bowman LC; Rochester RJ; Benaim E; Heslop HE; Krance RA; Horwitz EM; Cunningham JM; Tong X; Srivastava DK; Handgretinger R; Jones DP
    Biol Blood Marrow Transplant; 2005 Nov; 11(11):912-20. PubMed ID: 16275594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
    Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
    Kröger N; Zabelina T; Binder T; Ayuk F; Bacher U; Amtsfeld G; Lellek H; Schrum J; Erttmann R; Eiermann T; Zander A
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):454-62. PubMed ID: 19285633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine.
    Fang JP; Xu HG; Huang SL; Chen C; Huang K
    Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.
    Kobayashi R; Ariga T; Nonoyama S; Kanegane H; Tsuchiya S; Morio T; Yabe H; Nagatoshi Y; Kawa K; Tabuchi K; Tsuchida M; Miyawaki T; Kato S
    Br J Haematol; 2006 Nov; 135(3):362-6. PubMed ID: 17032176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Follow-up of leucocyte and reticulocyte counts for the prediction of early graft failure after non-HLA-identical BMT in children.
    Gerritsen EJ; Stam ED; Van den Berg H; Haraldsson A; Van Tol MJ; Vossen JM
    Bone Marrow Transplant; 1996 May; 17(5):781-7. PubMed ID: 8733698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Urgent allogeneic bone marrow transplantation using a preparative regimen of cyclophosphamide anti-human thymocytes rabbit globulin in a patient with severe aplastic anemia with pneumonia].
    Okamoto T; Marumo M; Saheki K; Okada M; Kawaguchi K; Takatuka H; Fujimori Y; Takemoto Y; Kohsaki M; Kanamaru A; Kakishita E
    Rinsho Ketsueki; 1996 Jan; 37(1):72-6. PubMed ID: 8683872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
    Ayuk F; Perez-Simon JA; Shimoni A; Sureda A; Zabelina T; Schwerdtfeger R; Martino R; Sayer HG; Alegre A; Lahuerta JJ; Atanackovic D; Wolschke C; Nagler A; Zander AR; San Miguel JF; Kröger N
    Haematologica; 2008 Sep; 93(9):1343-50. PubMed ID: 18641030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe aplastic anaemia--complete response to antilymphocyte globulin and cyclosporin.
    Jones-Lecointe A; Murphy A; Charles W; Daisley H; Pitt-Miller P
    West Indian Med J; 1999 Dec; 48(4):238-9. PubMed ID: 10639849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of severe aplastic anaemia with allogeneic bone marrow grafting [proceedings].
    Gluckman E; Devergie A; Marty M; Bussel A; Boiron M; Bernard J
    Pathol Biol (Paris); 1978 Jan; 26(1):36-7. PubMed ID: 29272
    [No Abstract]   [Full Text] [Related]  

  • 59. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
    Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T
    Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Second allogenic bone marrow transplantation after late graft rejection in a patient with severe aplastic anemia].
    Stamatović D; Balint B; Todorić-Zivanović B; Marjanović S; Lakić-Trajković Z; Malesević M
    Vojnosanit Pregl; 2000; 57(5):95-8. PubMed ID: 11213682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.